Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Phase 3

100%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 3Large-scale testing

3(100.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(3)

Detailed Status

Completed3

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 3

Trials by Phase

Phase 33 (100.0%)

Trials by Status

completed3100%

Recent Activity

0 active trials

Showing 3 of 3

completedphase_3

Safety Study of Ophthalmic Solution in Healthy, Normal Volunteers

NCT00223951

completedphase_3

Evaluation of Efficacy of Ophthalmic Solution in Induced Acute Allergic Conjunctivitis

NCT00241319

completedphase_3

Evaluation of Efficacy of Ophthalmic Solution in Induced Allergic Conjunctivitis

NCT00244543

Clinical Trials (3)

Showing 3 of 3 trials

NCT00223951Phase 3

Safety Study of Ophthalmic Solution in Healthy, Normal Volunteers

Completed

NCT00241319Phase 3

Evaluation of Efficacy of Ophthalmic Solution in Induced Acute Allergic Conjunctivitis

Completed

NCT00244543Phase 3

Evaluation of Efficacy of Ophthalmic Solution in Induced Allergic Conjunctivitis

Completed

All 3 trials loaded

Drug Details

Intervention Type: Drug
Total Trials: 3